Biofrontera Inc. Quarterly Nonoperating Income (Expense) in USD from Q3 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Biofrontera Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2020 to Q2 2024.
  • Biofrontera Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $4.83M.
  • Biofrontera Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $5.53M, a 587% increase year-over-year.
  • Biofrontera Inc. annual Nonoperating Income (Expense) for 2023 was $2.56M, a 85.8% decline from 2022.
  • Biofrontera Inc. annual Nonoperating Income (Expense) for 2022 was $18M.
  • Biofrontera Inc. annual Nonoperating Income (Expense) for 2021 was -$12.5M, a 846% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $5.53M $4.83M +$5.96M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$428K -$4.97M -$2.99M -151% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $2.56M $7.39M +$4.55M +160% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 -$1.99M -$1.72M -$2.8M -260% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $805K -$1.12M -$6.49M -121% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $7.29M -$1.98M -$10.7M -123% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $18M $2.84M +$15.5M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 $2.52M $1.07M +$975K +985% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $1.54M $5.36M +$5.29M +7560% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$3.75M $8.7M +$8.71M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$12.5M -$12.6M Oct 1, 2021 Dec 31, 2021 8-K 2023-10-03
Q3 2021 $99K +$679K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $70K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$5K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q3 2020 -$580K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.